Open AccessBranded Drug Companies are Successfully Asserting the Doctrine of Equivalents in Hatch-Waxman Litigation
Author(s) -
Christopher M. Holman
Publication year - 2021
Publication title -
ssrn electronic journal
Language(s) - English
Resource type - Journals
ISSN - 1556-5068
DOI - 10.2139/ssrn.4027544
Subject(s) - business , doctrine , drug , law and economics , law , pharmacology , economics , medicine , political science
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom